日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Baseline and three-month De Ritis ratio and gamma-glutamyltransferase as prognostic biomarkers in metastatic renal cell carcinoma treated with targeted therapy

基线和三个月时的德里蒂斯比值和γ-谷氨酰转移酶作为靶向治疗转移性肾细胞癌的预后生物标志物

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-026-43971-1
Aktepe, Oktay Halit; Ulasli, Tugce; Unek, Ilkay Tugba; Atag, Elif; Semiz, Huseyin Salih; Karaoglu, Aziz; Erman, Mustafa; Yalcin, Suayib
细胞生物学
肿瘤
肿瘤免疫
肾癌
发表日期：2026
文献求助 收藏

Baseline serum folic acid as a prognostic biomarker in metastatic renal cell carcinoma treated with targeted therapy

基线血清叶酸水平作为靶向治疗转移性肾细胞癌的预后生物标志物

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-026-04798-4
Aktepe, Oktay Halit; Izgor, Rezan Berkay; Ulasli, Tugce; Unek, Ilkay Tugba; Atag, Elif; Semiz, Huseyin Salih; Karaoglu, Aziz; Erman, Mustafa; Yalcin, Suayib
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2026
文献求助 收藏

Ki-67 and Platelet-to-Lymphocyte Ratio (PLR) as Predictors of Progression-Free Survival in Metastatic Breast Cancer Receiving CDK4/6 Inhibitors: Clinical Implications

Ki-67 和血小板/淋巴细胞比值 (PLR) 作为接受 CDK4/6 抑制剂治疗的转移性乳腺癌患者无进展生存期的预测指标：临床意义

期刊:Cancer Management and Research
影响因子:2.6
doi:10.2147/CMAR.S584786
Gokcek, Savas; Uzun, Mehmet; Unek, Ilkay Tugba
血小板
CDK4
Ki-67
肿瘤
肿瘤免疫
乳腺癌
细胞生物学
发表日期：2026
文献求助 收藏

Durvalumab-Based First-Line Chemoimmunotherapy in Advanced Biliary Tract Cancer: Real-World Outcomes and Prognostic Factors-A Turkish Oncology Group Study

以度伐利尤单抗为基础的一线化疗免疫疗法治疗晚期胆道癌：真实世界结果和预后因素——一项土耳其肿瘤协作组研究

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers18010101
Efil, Safa Can; Kus, Fatih; Koylu, Bahadir; Durukan, Bekir Mert; Bayram, Selami; Guzel, Halil Goksel; Ozturk, Banu; Muglu, Harun; Bilici, Ahmet; Kose, Fatih; Alan, Ozkan; Karapelit Agitoglu, Eda; Guner, Gurkan; Besen, Ali Ayberk; Helvaci, Kaan; Araz, Murat; Kacan, Turgut; Arslan, Cagatay; Unal, Ahmet; Eniseler, Emine Bihter; Biter, Sedat; Ekinci, Ferhat; Aslan, Ferit; Unek, Ilkay Tugba; Tas, Semra; Acar, Omer; Ates, Ozturk; Sakalar, Teoman; Akbas, Sinem; Karakas, Hilal; Akinci, Muhammed Bulent; Yalcin, Bulent; Yalcin, Suayip; Sendur, Mehmet Ali Nahit
肿瘤
胆管癌
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG)

FOLFIRINOX方案：壶腹腺癌的最佳辅助治疗方案？土耳其肿瘤协作组（TOG）的多中心研究

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17172730
Kalem, Ali; Kus, Tulay; Sahin, Taha Koray; Dizdar, Omer; Efil, Safa Can; Sendur, Mehmet Ali Nahit; Aykut, Talat; Araz, Murat; Bolek, Hatice; Urun, Yuksel; Sever, Nadiye; Bayoglu, Ibrahim Vedat; Cavdar, Eyyup; Sagıroglu, Muhammed Fatih; Gunes, Tugce Kubra; Ozcelik, Melike; Demirel, Nadide; Yıldız, Bulent; Karabuga, Berkan; Yalcıntas Arslan, Ulku; Gokcek, Savas; Unek, Ilkay Tugba; Saray, Seray; Aslan, Ferit; Acar, Omer; Erdogan, Atike Pınar; Seyyar, Mustafa; Aktas, Gokmen; Yalcın, Suayib
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Early Changes in Volumetric Body Composition Parameters Predict Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy

转移性肾细胞癌患者接受靶向治疗后，体成分参数的早期变化可预测其生存结果

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14093140
Aktepe, Oktay Halit; Erdemir, Ahmet Gurkan; Caliskan Yildirim, Eda; Demirciler, Erkut; Ulasli, Tugce; Guven, Deniz Can; Onur, Mehmet Ruhi; Unek, Ilkay Tugba; Semiz, Huseyin Salih; Erman, Mustafa; Yalcin, Suayib
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2025
文献求助 收藏

Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG)

转移性壶腹腺癌一线FOLFIRINOX方案与氟尿嘧啶类和吉西他滨类化疗方案的比较：土耳其肿瘤协作组（TOG）的多中心研究

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14165868
Kalem, Ali; Kus, Tulay; Gokcek, Savas; Unek, Ilkay Tugba; Sahin, Taha Koray; Dizdar, Omer; Sagıroglu, Muhammed Fatih; Bolek, Hatice; Urun, Yuksel; Yaslıkaya, Sendag; Bayram, Ertugrul; Sever, Nadiye; Bayoğlu, Ibrahim Vedat; Acar, Omer; Erdogan, Atike Pınar; Saray, Seray; Karabuga, Berkan; Arslan Yalcıntas, Ulku; Efil, Safa Can; Sendur, Mehmet Ali Nahit; Aykut, Talat; Araz, Murat; Gunes, Tugce Kubra; Ozcelik, Melike; Seyyar, Mustafa; Aktas, Gokmen; Yalcın, Suayib
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Association of Systemic Inflammatory Response Index and Prognostic Nutritional Index Scores with Sarcopenia in Patients with Metastatic Gastric Cancer

系统性炎症反应指数和预后营养指数评分与转移性胃癌患者肌少症的相关性

期刊:Medicina-Lithuania
影响因子:2.4
doi:10.3390/medicina61050785
Kanbur, Busra; Unek, Ilkay Tugba; Uzun, Mehmet; Ozturk, Caner; Yarol, Raif Can; Balci, Ali
胃癌
肿瘤
炎症
肿瘤免疫
炎症/感染
发表日期：2025
文献求助 收藏

Prognostic Impact of Glomerular Filtration Rate Decline on Survival Outcomes in Metastatic Renal Cell Carcinoma Treated with Targeted Therapy

肾小球滤过率下降对接受靶向治疗的转移性肾细胞癌患者生存结局的预后影响

期刊:Medicina-Lithuania
影响因子:2.4
doi:10.3390/medicina61091574
Aktepe, Oktay Halit; Arslan, Ahmet Melih; Yetginoglu, Ozge; Altas, Hatice; Sencan, Canberk; Akarca, Mehmet Sinan; Yildirim, Hasan Cagri; Semiz, Huseyin Salih; Unek, Ilkay Tugba; Karaoglu, Aziz; Erman, Mustafa; Yalcin, Suayib
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2025
文献求助 收藏

The Effect of HER2 Status on Gastric Cancer Survival and the Clinical Implications of the HER2-Low Definition: A Retrospective Study

HER2状态对胃癌生存的影响及HER2低表达定义的临床意义：一项回顾性研究

期刊:Medicina-Lithuania
影响因子:2.4
doi:10.3390/medicina61091675
Uzun, Mehmet; Gokcek, Savas; Kilinc, Melis; Ekinci, Ferhat; Avci, Tugay; Erdogan, Atike Pinar; Atag, Elif; Unek, Ilkay Tugba
胃癌
肿瘤
肿瘤免疫
HER2
发表日期：2025
文献求助 收藏